Pharmafile Logo

Glaucoma in perspective

- PMLiVE

Novo Nordisk pays $400m for EpiDestiny’s sickle cell drug

The candidate is expected to start a phase II trial in the coming months

- PMLiVE

FTI Consulting appoints Andrew Ward

He joins the healthcare communications practice as managing director

- PMLiVE

Reviews start for Pfizer’s wildcard lung cancer drug dacomitinib

Both EU and US regulatory advisors are currently assessing the drug

- PMLiVE

IQVIA collaborates with MuleSoft

Will deliver integration technology to life science companies

- PMLiVE

New industry standards group launched

Align Clinical CRO will improve clinical trial collaboration

A critical juncture for clinical data management

Data management functions are handling a much higher volume and diversity of data in response to the increasing scope and demands of global drug development programmes. Real-world data and evidence,...

- PMLiVE

A new era of smart pharma

How smarter pharmaceuticals and pharmacovigilance are transforming healthcare

Celgene building

Celgene boosts CAR-T stake again with Bluebird Bio deal

The US biotech could receive $70m in development milestones for the candidate

Sanofi reception

NICE rejects Sanofi’s Dupixent for atopic dermatitis at first call

Dupixent is still too expensive despite discount, says the UK’s cost effectiveness body

- PMLiVE

Ipsen bolsters leadership team

Ivana Magovcevic-Liebisch and Régis Mulot join the biopharma

- PMLiVE

Lucid’s first class of 2018 graduates from Lucid’s Futures Academy

Four graduates complete an eight-week training course

- PMLiVE

Health insurers will test blockchain for data handling

Aims to make health records more accurate and reliable

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links